Research15 Jul 2011 20:39
3D enters North American dental agreement
1 June 2011 | 11:22am
StockMarketWire.com - 3D Diagnostics Imaging has announced that its wholly owned subsidiary, CarieScan, has entered into an agreement with CoreStrength to manage its sales activity in both the U.S. and Canada (the "Agreement") for the CarieScan PRO (the easy to use hand held device for the early detection and monitoring of dental caries).
CarieScan will continue to work closely on a non-exclusive basis with Patterson Dental, its existing distribution partner in the U.S.
CoreStrength, which is well established in dental sales management, will provide CarieScan with access to a sales team of 22, substantially improving CarieScan's sales reach in those markets. Under the terms of the Agreement, CarieScan will contribute towards the costs of a jointly agreed marketing plan and towards certain costs incurred by CoreStrength in the delivery of its services.
The Agreement provides CarieScan with access to sales coverage for the whole of the North American territory on a predominantly commission only basis enabling the company to move forward on a significantly more cost effective manner.
As a consequence of entering into the Agreement and of moving away from directly employing sales support staff in the U.S. and Canada, the Directors believe that a significant proportion of the cost savings originally identified are now in place.
Commenting on the Agreement Graham Lay, 3D CEO, said: "I am delighted to be working with such a professional and experienced team and to achieve comprehensive coverage of the territory on such a cost effective basis."
At 11:22am: (LON:3DD) share price was +0.25p at 2.75p